Navigation Links
New study suggests that Arabica coffee could be extinct in the wild within 70 years
Date:11/7/2012

A study conducted by scientists at the Royal Botanic Gardens, Kew (UK), in collaboration with scientists in Ethiopia, reports that climate change alone could lead to the extinction of wild Arabica coffee (Coffea arabica) well before the end of this century. Wild Arabica is considered important for the sustainability of the coffee industry due to its considerable genetic diversity. The Arabicas grown in the world's coffee plantations are from very limited genetic stock and are unlikely to have the flexibility required to cope with climate change and other threats, such as pests and diseases. In Ethiopia, the largest producer of coffee in Africa, climate change will also have a negative influence on coffee production. The climate sensitivity of Arabica is confirmed, supporting the widely reported assumption that climate change will have a damaging impact on commercial coffee production worldwide. These are worrying prospects for the world's favourite beverage the second most traded commodity after oil, and one crucial to the economies of several countries. The research is published in PLOS ONE on 7 November 2012.

The study, which uses computer modelling, represents the first of its kind for wild Arabica coffee. In fact, modelling the influence of climate change on naturally occuring populations of any coffee species has never been undertaken. Surprisingly, even studies on plantation coffee have been limited, despite the concerns of farmers and other industry stakeholders.

The researchers used field study and 'museum' data (including herbarium specimens) to run bioclimatic models for wild Arabica coffee, in order to deduce the actual (recorded) and predicted geographical distribution for the species. The distribution was then modelled through time until 2080, based on the Hadley Centre Coupled Model, version 3 (HadCM3), a leading model used in climate change research, and the only one available that covered the desired ti
'/>"/>

Contact: Bronwyn Friedlander
pr@kew.org
44-020-833-25605
Royal Botanic Gardens Kew
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. U-M researchers to study food security across Michigan
2. UCLA researchers to study depression in breast cancer survivors
3. 2001-2002 drought helped propel mountain pine beetle epidemic, says CU study
4. Older adults who are frail much more likely to be food insufficient, according to national study
5. Study details essential role of trust in agricultural biotech partnerships
6. Brain may see more than the eyes, study indicates
7. WSU researcher to study ecology of antibiotic resistance
8. Social factors trump genetic forces in forging friendships, CU-led study finds
9. Clinical hypnosis can reduce hot flashes after menopause, Baylor study shows
10. New study to examine ecological tipping points in hopes of preventing them
11. New study reveals that every single junk food meal damages your arteries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... 11, 2015 Curemark LLC, a privately held ... a new Phase III double blind, randomized, placebo-controlled clinical ... CM-AT, on all children ages 3-8 with Autism. Previously, ... III double blinded clinical trial for CM-AT in children ... the digestive enzyme chymotrypsin. This new trial will help ...
(Date:5/8/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leading ... the executive management team will present at the following investor ... Telecom Conference Date: May 18, 2015 Time: 10:40am ... Cowen and Company Technology, Media & ... The New York Palace Hotel, New York, NY ...
(Date:5/6/2015)... 2015 LifeBEAM, a developer of bio-sensing technology, ... today that they will expand their partnership in bio-sensing ... cycling helmet and the first joint project between the ... in order to give cyclists more style choices and ... and Lazer announced their plan to release a new ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... of the 1962 Nobel Prize with Francis Crick and Maurice ... DNA, will present "Curing Incurable Cancer" and attend other events ... the James Graham Brown Cancer Center at the University of ... 5, at the Brown Theater, 315 W. Broadway, Louisville. Admission ...
... early stages of a major cause of failure in joint ... avoid additional surgery. More than 1.5 million total joint replacement ... is 90 per cent, almost 10 per cent of implants ... journal Molecular Pharmaceutics . Dong Wang and colleagues ...
... do not rely on oxygen may have played an important ... to a theory that UChicago researcher Albert Colman is testing ... Siberia. He has found that bacteria at the site ... that scientists must take into account as they attempt to ...
Cached Biology News:UofL hosts address by Nobel Laureate, DNA structure co-discoverer James Watson 2Cold case: Siberian hot springs reveal ancient ecology 2Cold case: Siberian hot springs reveal ancient ecology 3
(Date:5/21/2015)... NEW YORK , May 21, 2015  Prima ... biotechnology company that is striving to become a leader ... of cancer, recently announced that the final CVac data ... has shown a clear trend for a clinically meaningful ... ("SOC") in second remission patients. In the ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... DUBLIN , May 20, 2015 Research ... announced the addition of the "2015 Global ... to their offering. The primary goal ... of flow cytometry instruments and reagents. Key information ... drive the selection of flow cytometers, predominantly used ...
(Date:5/20/2015)... , May 20, 2015 ... presented preliminary data demonstrating the ability of the ... fibrosis (IPF) from other interstitial lung diseases (ILDs) ... the classifier,s potential to help thousands of patients ... ambiguity in IPF diagnosis – a frequent challenge ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Global Survey on Flow Cytometry Adoption Trends 2015 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5
Mycoplasma and virus tested...
Edited by I.H. Pawlowitzki, J.H. Edwards and E.A. Thompson (1997) • This volume covers: Linkage in dominant recessive and oligogenic disease, Model free (non-parametric) methods, Tools for gene ...
...
... analysis & visualization software. ... multiple samples. Combine Sequest ... increased confidence. Get more ... from your MS/MS experiments.14 ...
Biology Products: